BYNFEZIA Pen 2.5 mg/mL
octreotide acetate · INJECTION · Sun Pharmaceutical Industries, Inc.
BYNFEZIA Pen is a injection containing octreotide acetate at 2.5 mg/mL, taken subcutaneous. Manufactured by Sun Pharmaceutical Industries, Inc..
Key Facts
- Brand Name
- BYNFEZIA Pen
- Generic Name
- octreotide acetate
- NDC Code (Product)
62756-452- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Strength
- 2.5 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA213224
- Marketing Start
- 02/24/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is BYNFEZIA Pen used for?
BYNFEZIA Pen contains octreotide acetate. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is BYNFEZIA Pen a controlled substance?
BYNFEZIA Pen is not classified as a controlled substance by the DEA.
What is the generic name for BYNFEZIA Pen?
The generic name for BYNFEZIA Pen is octreotide acetate. There are 12 other brand versions of octreotide acetate.
What is the NDC code for BYNFEZIA Pen 2.5 mg/mL?
The NDC (National Drug Code) for BYNFEZIA Pen 2.5 mg/mL is 62756-452, listed by Sun Pharmaceutical Industries, Inc..
Other Octreotide Brands
See all →- OCTREOTIDE ACETATE50 ug/mL23155-687
- Octreotide Acetate1000 ug/mL25021-467
- Octreotide Acetate50 ug/mL71288-566
- Octreotide Acetate100 ug/mL0641-6175
- Octreotide Acetate1000 ug/mL0641-6178
- Sandostatin LAR Depot0078-0825
- Octreotide Acetate500 ug/mL68083-560
- Sandostatin50 ug/mL0078-0180
- Octreotide Acetate0480-9259
- Octreotide Acetate500 ug/mL0641-6176
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)